3 H]dTC were subjected to enzymatic digestion, and peptides containing 3 H were isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and/or reversed-phase high performance liquid chromatography. Isolated peptides were then subjected to NH 2 -terminal sequence analysis to identify specifically labeled residues. Within the ␣-subunit, 95% of specific incorporation was contained within a 20-kDa proteolytic fragment beginning at Ser-173, with ␣Tyr-190 the primary site of [ 3 H]dTC photoincorporation and ␣Cys-192 and ␣Tyr-198 labeled at lower efficiency. Within ␥-and ␦-subunits, specific labeling was contained within proteolytic fragments of 14 and 21 kDa, respectively, beginning at ␥Ala-49 and ␦Thr-51. ␥Trp-55 and ␦Trp-57 were identified as the sites of specific [ 3 H]dTC photoincorporation. Sequence alignment studies reveal ␥Trp-55 and ␦Trp-57 to be homologous residues at whose position in receptor subunit primary structure a unique pattern of conservation exists in all nAChR (neuronal and muscle). Specifically, all subunits that associate with an ␣-subunit to form an agonist site contain a tryptophan homologous to ␥Trp-55/␦Trp-57. This pattern of conservation may indicate a functional significance for tryptophan at that location in all nAChR agonist sites.
The nicotinic acetylcholine receptor (nAChR) 1 from the Torpedo ray electric organ is a ligand-gated ion channel comprised of four homologous subunits (␣ 2 ␤␥␦) that each traverse the lipid bilayer and associate about a central axis that is the ion channel. Although the Torpedo nAChR is the best characterized of the ligand-gated ion channels and the only one with a solved low resolution structure (2, 3) , the functional link between the binding of agonist and the gating of the ion channel has yet to be elucidated. Identification of amino acids in the agonist binding sites that interact with bound agonists or competitive antagonists in different nAChR conformational states will help define the structural components necessary for agonist binding and agonist-induced changes in structure.
The two agonist binding sites were first associated with the ␣-subunits by affinity labeling (4, 5) and ␣-bungarotoxin binding (6) . Subsequently, both agonist and competitive antagonist affinity and photoaffinity reagents have been utilized to identify amino acids within the ␣-subunit that are involved in the structure of the agonist site. From these studies, three discrete regions of ␣-subunit primary structure, centered around ␣Tyr-93, ␣Trp-149, and ␣Tyr-190 -␣Tyr-198, have been identified, and mutational analyses have begun to characterize the contributions of these residues to the binding of agonists and antagonists and to channel gating (for review see Refs. [7] [8] [9] .
Although agonists bind at equilibrium to the two ACh sites with similar affinities, many competitive antagonists bind nonequivalently (10, 11) . Therefore, at least for competitive antagonists, the binding sites themselves must differ, a difference that results from the fact that the sites are not contained entirely within the ␣-subunits but are actually located at interfaces between subunits, specifically at the ␣-␥ and ␣-␦ interfaces (1, 12) . Both biochemical and mutational studies have identified regions of the ␥-and/or ␦-subunits that may contribute to the agonist binding sites. In Torpedo nAChR, ␦Asp-180 has been identified by chemical cross-linking as a residue within 9 Å of ␣Cys-192-193 (13) , and charge neutralizing mutations at that position in mouse nAChR as well as the homologous ␥Asp-174 affect both agonist and competitive antagonist binding (14) . In other studies that examined the mouse muscle nAChR, amino acids at residues 116, 117, and 161 in ␥ (and the equivalent residues in ␦) determined the nonequivalent binding affinities for competitive antagonists (15, 16) , whereas amino acids at residues 34, 111, and 172 in ␥ (and the equivalent residues in ␦) determined the nonequivalent binding affinities for a peptide antagonist, ␣-conotoxin M1 (17) . These studies identify three regions within the non-␣-subunit primary structure that contribute to the agonist binding sites (near ␥ residues 34, 111-117, and 161-174 and the equivalent residues in ␦).
The competitive antagonist d-tubocurarine (dTC) binds to the two agonist sites with markedly different affinities (K d values of 30 nM and 8 M, (10) 3 H]dTC is covalently incorporated into the nAChR ␣-, ␥-, and ␦-subunits (1) . Although the efficiency of photoincorporation was low, with less than 5% of occupied sites labeled, the dependence of subunit labeling upon dTC concentration established that the high and low affinity dTC binding sites were located at the interfaces of the ␣-␥ and ␣-␦ subunits, respectively. In addition, the efficiency of [ 3 H]dTC photoincorporation within ␥-and ␦-subunits was similar to that seen for ␣-subunit. This pattern of photolabeling differed from that seen for another antagonist, [ 3 H]-p-(dimethylamino)benzenediazonium fluoroborate (DDF), which was incorporated into ␤-, ␥-, and ␦-subunits at Ͻ10% of its ␣ labeling (18) and for the agonist [ 3 H]nicotine, which was photoincorporated into ␥-subunit at ϳ25% the level of ␣, with no agonist-inhibitable incorporation in ␦-subunit detected (19) .
In this paper, we report on the major sites of specific photoincorporation of [ 3 H]dTC within the ␣-, ␥-, and ␦-subunits. Within the ␣-subunit, the sites of photoincorporation are the same as the amino acids identified by other antagonist affinity labels and (22) . The major sites labeled by [ 3 H]dTC in ␥ (␥Trp-55) and ␦ (␦Trp-57) define a fourth loop contributing to the agonist binding site from the non-␣-subunits. A preliminary report of these data was presented previously (23) .
EXPERIMENTAL PROCEDURES

Materials
nAChR-rich membranes were isolated from the electric organs of Torpedo californica (Marinus, Westchester, CA) or Torpedo nobiliana (Biofish Associates, Georgetown, MA) using the method described by Pedersen et al. (24) with the addition to the homogenization buffer of calpain inhibitors I and II (10 mg/liter, Boehringer Mannheim). The final membrane suspensions in 38% sucrose, 0.02% NaN 3 were stored at Ϫ80°C and contained 0.5-1.7 nmol of ACh binding sites/mg of protein as determined by an ultracentrifugation binding assay using [ 3 H]ACh (25) . [ 3 H]dTC was prepared as described by Pedersen and Cohen (1) . As determined by analytical HPLC, radiochemical specific activities of 30 and 20 Ci/mmol were obtained in two syntheses. Carbamylcholine, oxidized glutathione, and endoglycosidase H were obtained from Sigma. Recombinant N-Glycanase ® was obtained from Genzyme. Cyanogen bromide was obtained from Fluka. Analytical grade endoproteinase Lys-C was obtained from Boehringer Mannheim, Staphylococcal aureus glutamyl endopeptidase (V8 protease) was obtained from ICN Biochemicals, and trypsin (L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated) was obtained from Worthington.
Methods
Photolabeling of AChR-rich Membranes with [
3 H]dTC-Photolabeling of membrane suspensions on an analytical scale (i.e. aliquots of 40 g) was carried out in 96-well microtiter plates as described (1) , and protocols for photolabeling on a preparative scale (12 mg of protein) were designed to preserve important parameters from the analytical experiments. A 254-nm lamp (Spectroline EF-16) was positioned 7 cm above the membrane suspension contained in a polystyrene tray (4.5 cm ϫ 14 cm ϫ 2.5 cm deep) chosen so that a volume of 8 ml would have a depth (1.3 mm) similar to analytical labeling experiments. In this manner photolabeling conditions optimized on an analytical scale should remain appropriate for the preparative labeling. Freshly thawed nAChR-rich membrane suspensions were diluted 3-fold with Torpedo physiological saline (250 mM NaCl, 5 mM KCl, 3 mM CaCl 2 , 2 mM MgCl 2 , and 5 mM sodium phosphate, pH 7.0.) and pelleted at 17,000 ϫ g for 20 min at 3°C. A 25-gauge needle was used to resuspend the membranes to 1.25 mg of protein/ml in Torpedo physiological saline supplemented with 500 M oxidized glutathione that was included as an aqueous photochemical scavenger (1) . [ 3 H]dTC was then added to the desired concentration, as well as 1 mM carbamylcholine for the samples used to define nonspecific photolabeling. Membrane suspensions (10 mg of protein in 8 ml) were transferred to a polystyrene tray that was placed in a cold water bath in an enclosed box containing the UV lamp. The suspension was stirred using a magnetic stirrer while the box was flushed with argon for 30 min, and the suspensions were then irradiated for 3 min also with stirring. Following irradiation, the solutions were pelleted at 150,000 ϫ g for 30 min. Aliquots of supernatant were collected so that the free [ 3 H]dTC concentration could be determined by liquid scintillation counting, and the pellets were solubilized to 5 mg/ml in sample loading buffer (8% sucrose, 2% SDS, 0.06 M Tris, 0.4% glycerol, 0.0025% bromphenol blue, pH 6.8) for SDS-PAGE separation of the nAChR subunits.
SDS-Polyacrylamide Electrophoresis-nAChR subunits were resolved by SDS-PAGE using the Laemmli buffer system (26) with 8% acrylamide slab gels (1.5 mm thick) containing 0.32% bisacrylamide. Following electrophoresis, polypeptides were visualized by Coomassie Blue stain as described (27) , and bands containing the desired subunits were excised from the gel and soaked in distilled water for 30 min to remove residual precipitating reagents. nAChR subunits were then either isolated by passive elution from 1-to 2-mm gel fragments (28) , or an individual subunit gel slice was transferred to the well of a second, mapping gel ("in gel" (24, 29) ) for digestion with V8 protease. For V8 protease digestion, the subunit gel slice (from 5 mg of nAChR-rich membranes) was first incubated for 10 min in overlay buffer (5% sucrose, 0.1% SDS, 1 mM DTT, and 125 mM Tris-HCl, pH 6.8) and then placed in the well of the mapping gel that was composed of a 5-cm stacking gel (4% acrylamide) and a 10-cm separating gel (15% acrylamide, 0.4% bisacrylamide). The gel pieces were covered with 1 ml of overlay buffer containing 200 g of V8 protease, and electrophoresis was carried out at 125 V until the tracking dye reached the separating gel, at which time the power was shut off to allow for a digestion period of 3 h. Electrophoresis was then completed at 250 V. Appropriate regions of the mapping gels were excised, and protein was isolated from these gel fragments by passive elution during 16 h into 10 ml of buffer (100 mM NH 4 HCO 3 , 0.25% SDS, 2.5 mM DTT, pH 8.4). The eluted material was filtered through Whatman No. 1 filter paper to remove gel pieces, and the protein was concentrated to a volume of 0.5 ml by use of Amicon Centriprep-30 (for intact subunits) or Centriprep-10 (for subunit fragments) concentrators. Excess SDS was removed by acetone precipitation (75% acetone at Ϫ20°C for 1 h), and the pellet was resuspended in 100 -800 l of storage buffer (10 mM sodium phosphate buffer, pH 7.0, with 1 mM DTT, 1 mM EDTA, and 0.1% SDS). The yields of recovered subunits or proteolytic fragments were estimated by protein assay (Pierce micro BCA protein assay kit) and by liquid scintillation counting. From 10 mg of membrane protein, subunit yields were typically 400 g for ␣-subunit at 1-3 mg/ml and 300 g for the other subunits at 0.8 -2 mg/ml. 8 .0 (by diluting the storage buffer with 2 ϫ trypsin buffer). Cyanogen bromide digestion was carried out in 70% formic acid. Digestions with glycosidases were carried out in storage buffer (endoglycosidase H) or for N-Glycanase ® , in storage buffer supplemented with 0.5% Lubrol-PX (Pierce). Digestions were carried out at room temperature, and the enzyme concentrations and incubation times are indicated. Solution digests of subunits or subunit fragments were separated either on 15% acrylamide gels using the Laemmli buffer system or, when indicated, on a Tricine gel system described by Schä gger and von Jagow (30) . Digests carried out on an analytical scale (10 -40 g of protein) were fractionated on 0.75-mm thick gels. After electrophoresis, gels were fixed, stained with Coomassie Blue and destained, treated with En 3 Hance TM (Dupont) or Amplify TM (Amersham Corp.), dried, and analyzed by fluorography to determined the distribution of 3 H as described by Pedersen et al. (24) , except that gels were rinsed in 5% acetic acid, 2.5% glycerol (En 3 Hance TM treated only) before drying. The dried gels were exposed to Kodak X-Omat film for fluorographic analysis. Liquid scintillation counting was used to quantify the distribution of 3 H within gel lanes. The lanes were cut into 1-5 mm slices extending from the top of the spacer gel to the bottom of the separating gel, and the slices were rehydrated for 1 h in 0.1 ml of water and then counted in a toluene-based scintillation fluid containing 10% (v/v) TS-1 tissue solubilizer (RPI), 2.8 g/liter 2,5-diphenyloxazole, and 0.28 g/liter 1,4-bis[2-(5-phenyloxazolyl)]benzene after 2-3 days of incubation. When peptides were to be recovered from the dried gels after fluorography, Amplify TM , a water-based fluorographic reagent, was used. After fluorography the bands of interest were excised and rehydrated by soaking in H 2 O for 1 ⁄2 h, and the peptides were isolated from the rehydrated gel slices by passive elution as described previously. Molecular masses of labeled bands were estimated in relation to the following molecular mass markers: myosin (205 kDa), ␤-galactosidase (116 kDa), phosphorylase B (97.4 kDa), bovine albumin (66 kDa), and egg albumin (45 kDa), glyceraldehyde-3-phosphate dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), trypsinogen (24 kDa), soybean trypsin inhibitor (20.1 kDa), ␣-lactalbumin (14.2 kDa), cytochrome c (12.4 kDa), and cyanogen bromide-digested myoglobin fragments (17, 14.4, 10.6, 8 .2, and 6.2 kDa).
Peptide Purification by HPLC-Some [ 3 H]dTC-labeled fragments were further purified by reversed-phase HPLC using a Brownlee Aquapore C4 or C18 column (220 ϫ 2.1 mm). Cyanogen bromide digestions were separated by gradient filtration on a TPK 2000 SW column. The system components have been described (28) , and the elution solvents and conditions are described in the figure legends. Solvents were filtered through nylon filters (Rainin, 0.2 m pore size) and degassed prior to use, and all glassware was prerinsed 3 ϫ with the solvents.
Amino-terminal Sequence Analysis-An Applied Biosystems model 470A protein sequencer with an in-line model 120A PTH-amino acid analyzer was used to sequence samples of interest. PTH-labeled amino acids were dissolved in 126 l of 20% acetonitrile prior to injection onto the amino acid analyzer, and the system was calibrated so that after the 50-l injection loop on the analyzer was filled (40%), 50 l of the sample was collected in the fraction collector for determination of released radioactivity (40%). The actual cpm and pmol detected are reported. Samples for sequence analysis were loaded onto trifluoroacetic acidtreated glass fiber filters coated with 3 mg of Polybrene. Aliquots (up to 120 l) of samples in storage buffer that had been isolated from gels were loaded directly onto the filters. Pooled HPLC samples were dried by vacuum centrifugation, resuspended in a small volume of storage buffer (50 -100 l), and applied to the filters. Cycle yields for PTHderivatives were estimated from peak heights. Initial peptide mass (I) and repetitive yield (R) were calculated by nonlinear least squares regression (Sigma Plot) of the function f(x) ϭ I ϫ R x where f(x) is the observed mass released in cycle x. This function is displayed as dotted lines on the figures showing sequencing masses. PTH-derivatives of Ser, Cys, Arg, His, and Trp were excluded from the fits due to known problems with measuring mass yields of these residues.
RESULTS
Initial experiments confirmed the basic results of Pedersen and Cohen (1) , namely that 254 nm irradiation resulted in agonist-inhibitable incorporation of [ 3 H]dTC into AChR ␣-, ␥-, and ␦-subunits with incorporation into ␥-subunit when the high affinity dTC site was occupied and incorporation into ␦-subunit when the low affinity dTC site was occupied. Shown in Fig. 1 are results for a representative experiment where membrane suspensions were labeled with three different concentrations of [ 3 H]dTC. At high free dTC concentration (1 M), the efficiency of incorporation into the ␦-subunit was similar to that of the ␣-and ␥-subunits, and no specific incorporation into the ␤-subunit was detected.
Irradiation for 3 min at 254 nm resulted in incorporation into only a small fraction (Ͻ5%) of occupied dTC sites. Longer irradiation times resulted in significant cross-linking between subunits without a corresponding increase in [ 3 H]dTC incorporation into the remaining uncross-linked subunits, while shorter times decreased incorporation (data not shown). Therefore, sample irradiation was limited to 3 min. To determine the effects of irradiation on dTC, the concentrations of free [ 3 H]dTC were measured by analytical HPLC before and after a photolabeling of nAChR-rich membranes. The concentration of free [ 3 H]dTC, which was initially 1.6 M, decreased to 1.2 M after 3 min of 254 nm UV irradiation (28% decomposition).
Membrane suspensions (10 mg of protein) were photolabeled with [ 3 H]dTC in the absence or presence of carbamylcholine (carb), and nAChR subunits were isolated by preparative slab gel electrophoresis. ␣-Subunit preparations contained 400 -500 g of protein, and ␤-, ␥-, and ␦-subunits contained 200 -300 g.
Tritium incorporation varied with the free [
3 H]dTC concentration, but in a typical experiment at 600 nM free ligand, ␣-, ␥-, and ␦-subunit preparations incorporated 1340, 1200, and 700 cpm/g, respectively, each of which was 75% specific, i.e. inhibitable by agonist. In contrast to analytical SDS-PAGE results ( Fig. 1) , the ␤-subunit preparations also incorporated 3 H at a lower level (380 cpm/g), with 50% agonist-inhibitable. However, amino-terminal sequence analyses of isolated subunit preparations revealed that the samples were not homogeneous. A representative ␣-subunit preparation contained an aminoterminal proteolytic fragment of ␤-subunit at 9% of the ␣-subunit level. Isolated ␤-subunit contained amino-terminal proteolytic fragments of ␥-and ␦-subunit at 10 and 27% the level of ␤-subunit, respectively, and ␥-and ␦-subunit preparations were contaminated with the Na ϩ /K ϩ -ATPase ␤-subunit at 30 -60% of the mass level of the nAChR subunits. The presence of these contaminating polypeptides was not unexpected, since a proteolytic fragment of ␤-subunit with mobility similar to ␣-subunit as well as ␥-and ␦-subunit fragments with mobility similar to ␤-subunit are present in the membrane suspensions (1, 31) , and ATPase ␤-subunit fragments have been identified in digests of nAChR ␥-and ␦-subunits (28, 31).
Mapping of [ 3 H]dTC-labeled Sites in nAChR Subunits by V8
Protease-Peptide mapping with S. aureus glutamyl endopeptidase (V8 protease) was employed to determine the distribution of 3 H within four large nonoverlapping ␣-subunit fragments reproducibly produced by V8 protease (Table I) 3 H]dTC were determined by HPLC as follows: , 4.5 nM; OE, 120 nM; q, 970 nM; Ⅺ, 1450 nM. Aliquots (37 g) of the photolabeled membranes were analyzed by SDS-PAGE. After the gel was stained and destained, the lanes were cut into 2-mm slices, and the distributions of 3 H were determined by liquid scintillation counting. Also indicated are the positions of the four nAChR subunits, the molecular weight markers, and the tracking dye (TD).
Sites of [ 3 H]d-Tubocurarine Photoincorporation in nAChR
Fragment ␣V8-4 begins at Ser-1, and ␣V8-10 begins at Asn-339 and extends to the ␣-subunit carboxyl terminus (27) . As noted by Pedersen et al. (24) , it is difficult to fully resolve ␣V8-20 from ␣V8-18, but this can be accomplished by the shift of mobility associated with deglycosylation of Asn-141. Based upon counting of excised gel slices, Ͼ95% of the 3 H incorporated in ␣-subunit was contained within ␣V8-20 in proteolytic digests of either glycosylated or deglycosylated ␣-subunit. More than 90% of that incorporation was specific, as evidenced by the reduced 3 H incorporation seen in fragments isolated from nAChRs labeled in the presence of carbamylcholine. Levels of specific incorporation recovered in gel bands corresponding to ␣V8-18, ␣V8-10, and ␣V8-4 were Յ2% that of ␣V8-20. For the 18-kDa gel band, this low level of specific 3 H incorporation was most likely not associated with ␣V8-18, since no shift of 3 H to ␣V8-12 was observed for deglycosylated ␣-subunit cleaved with V8 protease.
Digestion with V8 protease was also used to provide an initial mapping of the sites of [ 3 H]dTC incorporation in the nAChR non-␣-subunits. Subunits, eluted from SDS-PAGE separation of [ 3 H]dTC-labeled membranes, were digested and fractionated by SDS-PAGE. Based upon gel slice analysis (Fig. 2) , 81% of the specific 3 H incorporation in the ␥-subunit was recovered in a fragment of ϳ14 kDa (␥V8-14), and 80% of the specific incorporation in the ␦-subunit was in a band of 21 kDa (␦V8-21). For this labeling experiment, isolated ␤-subunit also appeared to be labeled specifically, with fragments of 14 and 21 kDa identified after digestion with V8 protease accounting for 94% of the agonist-inhibitable 3 H incorporation. Thus for the ␤-subunit preparation, the two 3 H-labeled fragments produced by V8 protease co-migrated with the 3 H-labeled ␥-and ␦-subunit fragments. In view of this and the fact that all ␤-subunit preparations that were sequenced contained ␥-and ␦-subunit fragments, it appears most likely that the apparent specific labeling in ␤-subunit preparations resulted from contaminating fragments of ␥-and ␦-subunits.
Sites of [ 3 H]dTC
Photoincorporation into the ␣-SubunitLabeled ␣V8-20 was isolated by preparative slab gel electrophoresis. Amino-terminal sequence analysis (Fig. 3) of an aliquot of ␣V8-20 established the presence of ␣V8-20 with the primary sequence beginning at ␣Ser-173 (285 pmol), as well as secondary sequences beginning at ␣Ser-162 (56 pmol), ␣Thr-52 (40 pmol), and ␣Val-46 (33 pmol). Peaks of 3 H release were observed in cycles 18, 20, and 26 that resulted from the specific labeling of ␣-subunit, since this labeling was greatly reduced or abolished for ␣V8-20 isolated from nAChR-rich membranes labeled in the presence of 1 mM carbamylcholine. The peptides beginning at ␣Thr-52 and ␣Val-46 (␣V8-18) were previously shown to not contain sites of specific [ 3 H]dTC photoincorporation (Table I) . Furthermore, any labeled residues beyond the 11th cycle from ␣Ser-162 would have been encountered earlier from the ␣Ser-173 peptide sequence. Therefore, the 3 H release in cycles 18, 20, and 26 was likely to reflect incorporation of [ 3 H]dTC into ␣Tyr-190, ␣Cys-192, and ␣Tyr-198 from the primary peptide in the sample beginning at ␣Ser-173.
Two further experiments confirmed that ␣Tyr-190 was the principal site of [ 3 H]dTC photoincorporation in ␣-subunit. First, when an endoproteinase Lys-C digest of 3 H-labeled ␣-subunit was fractionated on a 15% acrylamide gel, 3 H-labeled peptide migrated as a single, sharp band near the dye front (Fig. 4A ). Sequence analysis (Fig. 4B) 3 H-labeled peptide was recovered in a single peak. Sequence analysis revealed the presence of two peptides, one beginning at ␣Lys-179 and the other at ␣Ile-283. Both were present at similar levels (30 pmol) and sequenced poorly (R ϭ 70%), presumably due to the acidic conditions used to fraction- 3 H]dTC-labeled ␣-subunit (75,000 cpm Ϫcarb; 11,000 cpm ϩcarb) were treated with 2.5 milliunits of endoglycosidase H overnight. The digests, together with untreated aliquots (no endoglycosidase H), were loaded onto a 15% acrylamide gel and digested with V8 protease (5 g/lane) during stacking. After electrophoresis, the gel was stained with Coomassie Blue, and the stained bands containing the four known ␣-subunit peptides (␣V8 -20, ␣V8 -18, ␣V8 -10, and ␣V8 -4) were excised and counted in gel scintillation cocktail. , and the labeled subunits were isolated by SDS-PAGE. The specific activities ( 3 H cpm/g protein) of the isolated subunits were as follows: ␦ (Ϫcarb), 1685; ␦ (ϩcarb), 238; ␥ (Ϫcarb), 1480; ␥ (ϩcarb), 436; ␤ (Ϫcarb), 1217; and ␤ (ϩcarb), 345. Samples of ␤, ␥, and ␦ (10 g each) were loaded onto a 15% acrylamide gel and digested during stacking with V8 protease (3 g/lane).
3 H distribution after electrophoresis was determined by scintillation counting of the gel lanes cut in 5-mm segments (q, Ϫcarb; E, ϩcarb). Migrations of molecular weight standards are shown on the top of the figure. For ␦-subunit, the major peak of 3 H was centered at 21 kDa (␦V8-21), and for ␥-subunit, it was at 14 kDa (␥V8-21). For the ␤-subunit preparation peaks of 3 H were observed with similar mobilities as ␦V8-21 and ␥V8-14. Counts per min recovered per lane (as % of cpm loaded) were ␦ Ϫ carb, 101%; ␦ ϩ carb, 80%; ␥ Ϫ carb, 81%; ␥ ϩ carb, 66%; ␤ Ϫ carb, 62%; and ␤ ϩ carb, 66%.
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ate the digest (32).
3 H release was observed in cycle 12, corresponding to ␣Tyr-190 from the ␣Lys-179 peptide (data not shown). Unfortunately, substantial lag after that first peak prevented interpretation of any subsequent 3 H release. The V8 protease mapping analysis of the ␣-subunit established that any specific [ 3 H]dTC incorporation in the ␣V8-18 peptide was less than 2% the incorporation in ␣V8-20 (Table I) . As a further attempt to detect [ 3 H]dTC incorporation at or near the other ␣-subunit residues localized to the agonist site (␣Tyr-93 and ␣Trp-149, both of which reside on ␣V8-18 (20, 22) ), a sample of ␣V8-18 (30 g, 8200 cpm) isolated from nAChR-rich membranes photolabeled with [ ]dTC-labeled ␦-subunit with V8 protease produces a labeled fragment of 21 kDa (␦V8-21). ␦V8-21 was isolated as described under "Experimental Procedures" by preparative slab gel electrophoresis. When aliquots were sequenced (Fig. 5A ), there was a prominent peak of 3 H release at cycle 7 and a minor peak at cycle 10, release that resulted from specific photolabeling of ␦-subunit since no release above background was detected for ␦V8-21 isolated from AChRs labeled in the presence of carbamylcholine. Analysis of released PTH-derivatives indicated the presence of five different sequences. The primary sequence began at ␦Thr-51 (50 pmol), and secondary sequences began at ␦Thr-48 (12 pmol) and ␦Ile-192 (12 pmol) as well as Na
peptides beginning at Gly-173 (15 pmol) and Tyr-231 (15 pmol).
To determine which of these peptides was the source of 3 H released in cycles 7 and 10, advantage was taken of the fact that the ␦-subunit fragments contained N-linked glycosylation sites. The T. californica nAChR ␦-subunit contains 3 sites for N-linked glycosylation (Asn-70, Asn-143, and Asn-208; Fig.  5B ), each of which is glycosylated (33) . Aliquots of labeled ␦V8-21 were treated with endoglycosidase H to remove high mannose and some hybrid carbohydrates, but not complex carbohydrates (34), or with N-Glycanase ® , which releases all Nlinked carbohydrates (35) . These samples, as well as untreated controls, were analyzed by SDS-PAGE. Inspection of the fluorogram (Fig. 6 ) revealed that digestion with endoglycosidase H shifted the 3 H-labeled peptide from 21 to 17 kDa, whereas digestion with N-Glycanase ® shifted the peptide from 21 to 11.5 kDa. These results indicated that the labeled peptide in ␦V8-21 contained at least two of the three N-linked glycosylation sites in ␦-subunit.
When an aliquot of [ 3 H]dTC-labeled ␦V8-21 was treated with endoglycosidase H and then purified by reversed-phase HPLC, approximately 65% of the 3 H was recovered in a broad peak centered at 40% organic (Fig. 7A) . The four fractions containing specifically labeled material were pooled and sequenced. The 3 H]dTC (Ϯcarb) and separated by SDS-PAGE. After staining and destaining, the bands containing the ␣-subunit were excised and transferred to a 15% polyacrylamide "mapping" gel for digestion with with 200 g of V8 protease, as described under "Experimental Procedures." ␣V8-20 (Ϯcarb) was isolated from the gels with specific activities of 6600 cpm/g (Ϫcarb) and 790 cpm/g (ϩcarb). Aliquots of ␣V8-20 (50 g) were sequenced for 38 cycles of Edman degradation (q, Ϫcarb, 300,000 cpm loaded, 90,000 left on the filter; E, ϩcarb, 40,000 cpm loaded, 9,000 left on the filter). The primary sequence from the Ϫcarb sample began at ␣Ser-173 (Ⅺ, I ϭ 285 pmol, R ϭ 91%). (The dotted line represents a best fit of the mass values from the ␣Ser-173 peptide, calculated as described under "Experimental Procedures.") Secondary sequences were also detected beginning at ␣Ser-162 (I ϭ 56 pmol, R ϭ 92%), ␣Thr-52 (I ϭ 40 pmol, R ϭ 88%), and ␣Val-46 (I ϭ 33 pmol, R ϭ 93%). The same sequences at similar mass levels were also present in the ϩcarb sample (data not shown). Release of 3 H was detected in cycles 18, 20, and 26 (3500, 700, and 400 cpm, respectively) corresponding to ␣Tyr-190, ␣Cys-192, and ␣Tyr-198 from the primary sequence detected. 
Sites of [ 3 H]d-Tubocurarine Photoincorporation in nAChR
3 H release profile (Fig. 7B) showed a peak in cycle 7 and was essentially the same as that seen in Fig. 5A for ␦V8-21 prior to purification. The only peptide sequences detected began at ␦Thr-51 (8 pmol) and at ␦Thr-48 (1 pmol). The other three peptides detected in Fig. 5 were not present (I Յ 0.5 pmol An alternative digestion strategy utilized in conjunction with radiochemical sequence analysis also led to the conclusion that ␦Trp-57 was the principal site of [ 3 H]dTC photolabeling of ␦-subunit. The primary structure of the T. californica ␦-subunit adjacent to ␦Trp-57 (Fig. 8A ) includes potential trypsin cleavage sites at ␦Lys-46, which is amino-terminal to the identified V8 protease cleavage sites (␦Glu-47 and ␦Glu-50), and at ␦Arg-66. A sample of ␦-subunit (isolated from [ 3 H]dTC photolabeled nAChR-rich membranes) was digested with trypsin and fractionated by reversed-phase HPLC. About 80% of the loaded 3 H was recovered in a single peak at 25% organic (Fig. 8B) 3 H]dTC (Ϯcarb) and fractionated by SDS-PAGE. After staining and destaining, the band containing ␦-subunit was excised and transferred to a 15% acrylamide mapping gel for digestion with 200 g of V8 protease as described under "Experimental Procedures." ␦V8-21, identified by Coomassie Blue stain, was isolated from the gels with specific activities of 4300 cpm/g (Ϫcarb) and 220 cpm/g (ϩcarb). A, 3 H release profiles from 22 cycles of Edman degradation of ␦V8-21 (Ϫcarb, q, 100,000 cpm loaded, 33,000 left on the filter; ϩcarb, E, 5,500 cpm loaded, 1,400 left on the filter). For the Ϫcarb sample, the primary sequence began at ␦Thr-51 (Ⅺ, I ϭ 50 pmol, R ϭ 88%). The dotted line represents a best fit of the mass values, calculated as described under "Experimental Procedures." Four secondary sequences were also detected, two from ␦-subunit; ␦Thr-48 (I ϭ 12 pmol, R ϭ 85%) and ␦Ile-192 (I ϭ 12 pmol, R ϭ 81%), and two from the ␤-subunit of the Na ϩ /K ϩ ATPase; Tyr-231 (I ϭ 15 pmol, R ϭ 93%) and Gly-173 (I ϭ 14 pmol, R ϭ 94%): The same sequences at similar mass levels were also present in the ϩcarb sample (data not shown). B, a linear representation of the ␦-subunit sequence including the locations of the amino termini of the ␦-subunit fragments listed above (2), the sites of N-linked glycosylation (CBO, Asn-70, Asn-143, and Asn-208), and the four predicted membrane spanning regions, denoted as M1-M4. A, HPLC purification of ␦V8-21 (Ϫcarb, 27,000 cpm recovered) with 3 H (q) elution (determined by counting 1% of 11 HPLC fractions spanning the 3 H peak and 100% of the other fractions), 280 nm absorbance (⅐⅐⅐) and % organic (---). The four peak fractions of 3 H were pooled (as were the corresponding fractions from the ϩcarb sample), concentrated, and sequenced. B, the 3 H release profiles from 24 cycles of Edman degradation (q, Ϫcarb, 22,000 cpm loaded, 6,000 cpm left on filter; E, ϩcarb, 1,100 cpm loaded, 100 cpm left on the filter). Two peptides were detected beginning at ␦Thr-51 (Ⅺ, I ϭ 8 pmol, R ϭ 82%) and ␦Thr-48 (IϽ1 pmol). The dotted line represents a best fit of the mass values of the ␦Thr-51 peptide, calculated as described under "Experimental Procedures." Release of 3 H in cycle 7 (430 cpm) was consistent with [ 3 H]dTC incorporation into ␦Trp-57 (215 cpm/pmol) from the peptide beginning at ␦Thr-51. The ϩcarb sample contained ␦Thr-51 (I ϭ 3 pmol, data not shown).
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Fig . 8C , displayed major release of 3 H in cycle 11 (1,000 cpm). The other half of the material was further digested with V8 protease and then sequenced. The 3 H release profile for this sample (Fig. 8D ) was characterized by a peak of release in cycle 7 (900 cpm), with no release detected in cycle 11. Release of 3 H in cycle 7 and the absence of release in cycle 11 indicated that V8 protease must have removed four amino acids from the amino-terminal end of the labeled peptide sequenced in Fig.  8C . This result was consistent with our digestion strategy (Fig.  8A) and confirmed ␦Trp-57 as the primary site of [ 3 H]dTC incorporation in ␦-subunit. The expected peptides were not detected by mass with Edman degradation. Since the predicted trypsin peptides were between 16 and 20 amino acids long (Fig.  8A) , it was anticipated that the covalent attachment of [ 3 H]dTC to these peptides altered their HPLC retention times enough to cause a separation of the labeled and the unlabeled samples.
Major Site of [
3 H]dTC Incorporation in ␥-Subunit-␥V8-14 was isolated by preparative SDS-PAGE from a V8 protease digest of labeled ␥-subunit. Sequence analysis of ␥V8-14 (Fig. 9) established that there was specific release of 3 H in the 7th cycle of Edman degradation and that the sample contained ␥-subunit fragments beginning at ␥Ala-49, ␥Val-102, and ␥Leu-373, each present at similar mass levels (Table II) . To determine which of these peptides was the source of the 3 H released in cycle 7, advantage was taken of the fact that they were likely to be differentially glycosylated. The T. californica nAChR ␥-subunit contains one simple and one complex N-linked carbohydrate (33) , with potential sites of glycosylation within the fragments beginning at ␥Ala-49 (Asn-68) and ␥Val-102 (Asn-141). Asn-431, the only potential N-linked glycosylation site within the ␥Leu-373 fragment, is not glycosylated (36) . Aliquots of ␥V8-14 were digested with endoglycosidase H or N-Glycanase ® . These digests, along with an untreated control, were fractionated by SDS-PAGE, and the distribution of 3 H was determined by gel slice analysis (Fig. 10) . The mobility of the prominent 3 Hlabeled peptide was unaffected by endoglycosidase H, and treatment with N-Glycanase ® converted the labeled peptide to a band of 8 kDa. Thus the major site of 3 H incorporation was in a peptide containing an endoglycosidase H-resistant carbohydrate, eliminating the possibility that the primary site of labeling is on the ␥Leu-373 peptide.
To determine which of the remaining ␥V8-14 peptides (␥Ala-49 or ␥Val-102) contained an endoglycosidase H-resistant N-linked carbohydrate, an aliquot of ␥V8-14 was digested with endoglycosidase H and fractionated by SDS-PAGE on a 16.5% T, 3% C Tricine gel, and protein was eluted from the bands of 14 and 8 kDa that were identified by Coomassie Blue stain. Seventy-nine percent of the loaded 3 H was recovered in the 14-kDa band, and amino-terminal sequence analysis of this material (Table III) 3 H]dTC, and the labeled subunits were isolated by SDS-PAGE. ␦-Subunit (180 g, 200,000 cpm) was incubated with 120 g of trypsin overnight at 25°C, and the digest was then fractionated by reversed-phase HPLC (C4 column, 0.25 ml/min, in 10 mM NaPO 4 , pH 7.0, with a gradient of 0 -55% acetonitrile in 55 min). A, the amino acid sequence of the Torpedo nAChR ␦-subunit between Leu-45 and Leu-67, with potential trypsin cleavage sites (2) and known V8 protease cleavage sites (1) denoted. B, HPLC elution profile of 3 H (q) and 280 nm absorbance (⅐⅐⅐), as well as % organic (---). Aliquots (4%) of each fraction were counted, and 100% of injected 3 H was recovered. The four peak fractions of 3 H (95,000 cpm) were pooled, concentrated, and divided into equal aliquots for sequence analysis before (C) and after redigestion with V8 protease (D). C, 3 H (q) release profile after digestion with trypsin (46,000 cpm loaded, 14,000 cpm left after 20 cycles of Edman degradation).
3 H release in cycle 11 (1,000 cpm) was consistent with trypsin cleavage at ␦Lys-46 and [ 3 H]dTC incorporation at ␦Trp-57. D, 3 H (q) release profile for the sample digested overnight at 25°C with 100 g of V8 protease (46,000 cpm loaded, 6,400 cpm left after 20 cycles of Edman degradation). Tritium release in cycle 7 (900 cpm) was consistent with V8 protease cleavage after ␦Glu-50 and [
3 H]dTC incorporation at ␦Trp-57. Neither of the expected sequences were detected by mass, probably due to separation of labeled and unlabeled peptide by HPLC.
FIG. 9. Sequence analysis of [
3 H]dTC-labeled ␥V8-14 isolated by SDS-PAGE. nAChR-rich membranes (10 mg, 8 nmol Ach binding sites) were photolabeled with 1.1 M [ 3 H]dTC (Ϯcarb) and fractionated by SDS-PAGE. After staining and destaining, the band containing ␥-subunit was excised and transferred to a 15% acrylamide mapping gel for digestion with 200 g of V8 protease as described under "Experimental Procedures." ␥V8-14, identified by Coomassie Blue stain, was isolated from the gels with specific activities of 1,800 cpm/g (Ϫcarb) and 280 cpm/g (ϩcarb). Aliquots of ␥V8-14 (14 g) were sequenced. A, 3 H release profiles during 19 cycles of Edman degradation (q, Ϫcarb, 25,000 cpm loaded, 8,500 left on the filter; E, ϩcarb, 4,000 cpm loaded, 1, 300 left on the filter). For the Ϫcarb sample, three ␥-subunit peptides were detected at similar mass levels: ␥Ala-49, ␥Val-102, and ␥Leu-373 (see Table II ). The same three peptides were also present in the ϩcarb sample at similar mass levels. B, a linear representation of the ␥-subunit sequence including the locations of the amino termini of the ␥-subunit fragments identified above (2), the sites of N-linked glycosylation (CBO, Asn-68, Asn-141), and the four predicted membrane spanning regions, denoted as M1-M4. An additional V8 protease cleavage site, detected from previous work, is also noted ().
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␥Val-102 peptide (Յ1 pmol). Prominent release of 3 H (2,000 cpm) was detected in the 7th cycle. Sequence analysis of the 8-kDa band (Table IV) , which contained 1% of the 3 H loaded on the gel, established the new location of the ␥Val-102 peptide (17 pmol) as well as the presence of ␥Glu-1 (13 pmol) and some ␥Leu-373 (9 pmol), but no ␥Ala-49 (Յ1 pmol). No significant 3 H release was noted from 23 cycles of Edman degradation of the 8-kDa band. From these data it was noted that release of 3 H in cycle 7 was seen only for samples containing the ␥Ala-49 peptide and that there was no correlation between the presence of the ␥Val-102 peptide and 3 H release in cycle 7. Thus, the release of 3 H in cycle 7 indicates specific photoincorporation of [ 3 H]dTC into ␥Trp-55.
To confirm this identification, endoproteinase Lys-C was used to provide an alternative fragmentation of [ 3 H]dTC-labeled ␥-subunit. Based upon the occurrence of lysines in ␥-subunit, digestion with endoproteinase Lys-C would generate a fragment extending from ␥Glu-47 to ␥Lys-192 that would be readily isolated by SDS-PAGE and would incorporate 3 H in the 9th amino acid. ␥-Subunit, isolated from nAChR membranes photolabeled with [ 3 H]dTC, was digested extensively with endoproteinase Lys-C. An aliquot of the digest was fractionated by analytical SDS-PAGE, and 58% of the 3 H was recovered in a band centered at 27 kDa, and 21% was recovered in a shoulder at 23 kDa (Fig. 11A) . The remainder of this digest was fractionated on a preparative slab gel, which was prepared for fluorography. The resulting fluorogram was used as a template to excise the two bands containing 3 H, and the labeled material was eluted from the rehydrated gel slices. Sequence analysis of the material eluted from band P (Fig. 11B) displayed 3 H release in cycle 9 and the presence of two peptides, one beginning at ␥Glu-47 (30 pmol) and a second beginning at ␥Thr-24 (23 pmol 3 H]dTC (Ϯcarb) and fractionated by SDS-PAGE. After staining and destaining, the gel piece containing the ␥-subunit band was excised and transferred to a second 15% acrylamide mapping gel for digestion with 200 g of V8 protease as described under "Experimental Procedures." ␥V8-14 was isolated from the gels with specific activities of 1150 cpm/g (Ϫcarb) and 280 cpm/g (ϩcarb). Aliquots of ␥V8-14 (2 g) were incubated overnight (25°C) without glycosidase (A), with 5 milliunits of endoglycosidase H (B), or with 0.5 units of N-Glycanase ® (C). The samples were then analyzed by SDS-PAGE (Tricine gel, 16.5% T, 6% C). The gel was stained, destained, dried, and the distribution of 3 H was determined by counting the gel lanes cut into 2-mm slices (2 mm per slice; q, Ϫcarb; E, ϩcarb). The apparent molecular masses for the 3 H containing bands were 14.4 kDa for A and B, and 8.2 kDa for C, as calculated from the mobilities of molecular weight markers. 3 H]dTC and fractionated by SDS-PAGE. After staining and destaining, the band containing ␥-subunit was excised and transferred to a 15% acrylamide mapping gel for digestion with 200 g of V8 protease as described under "Methods." ␥V8 -14 was isolated with a specific activity of 1,900 cpm/g. ␥V8 -14 (150 g, 300,000 cpm) was digested with 50 milliunits of endoglycosidase H (overnight at 25°C), and fractionated by SDS-PAGE (Tricine 16.5% T, 3% C), and the resulting gel was stained and destained. The Coomassie Blue-stained bands present at 14 and 8 kDa were excised, and the material was eluted and concentrated for sequence analysis. Shown in Table II are masses of detected PTH-derivatives and 3 H release for the 14-kDa band (25,000 cpm loaded, 6,800 cpm left on the filter after 18 cycles of Edman degradation). The fragments beginning at ␥Ala-49 (I ϭ 20 pmol, R ϭ 90%) and ␥Leu-373 (I ϭ 36 pmol, R ϭ 89%) were detected whereas ␥Val-102 was not present (Ͻ1 pmol). Data for the 8-kDa band are in Table IV Fig. 9 . The three ␥V8 -14 peptides were present at similar masses: ␥Ala-49 (I ϭ 19 pmol, R ϭ 84%), ␥Val-102 (I ϭ 9 pmol, R ϭ 91%), and ␥Leu-373 (I ϭ 23 pmol, R ϭ 86%). Similar mass levels for the same three peptides were detected in the ϩcarb sample (Ϫcarb, 25,000 cpm loaded, 8,500 cpm left on the filter and ϩcarb, 3,500 cpm loaded, 1,300 cpm left on the filter after 19 cycles of Edman degradation). 3 H]dTC photoincorporation into nAChR ␣-, ␥-, and ␦-subunits was inhibitable by agonist. The concentration dependence of subunit labeling noted previously (1) was reproduced, consistent with the localization of the high and low affinity binding sites at the ␣-␥ and ␣-␦ interfaces, respectively. Also consistent with Pedersen and Cohen (1), we observed no agonist-inhibitable [ 3 H]dTC incorporation into the ␤-subunit when photolabelings were evaluated at an analytical scale (Fig.  1) . In contrast, when nAChR-rich membranes were photolabeled on a preparative scale and subunits were isolated by SDS-PAGE, significant agonist-inhibitable 3 H incorporation was detected in ␤-subunit samples. However, amino-terminal sequence analysis of the isolated subunit preparations as well as peptide mapping studies by use of V8 protease (Fig. 2) indicate that the observed specific 3 H incorporation most likely resulted from contamination of the ␤-subunit preparations by fragments of ␥-and/or ␦-subunit. Proteolytic fragments of ␥ and ␦ with mobilities similar to ␤ occur in many nAChR membrane preparations (1, 31) . Therefore, the bulk of the evidence supports the conclusion that [ 3 H]dTC does not specifically photoincorporate into the ␤-subunit.
[ 3 H]dTC is not the only agonist site affinity probe that reacts with amino acids in non-␣ subunits. [ 3 H]DDF is photoincorporated into ␤-, ␥-, and ␦-subunits at efficiencies Յ10% of its incorporation into ␣-subunit (18), whereas [ 3 H]nicotine labeled ␥-subunit at 25% the level of ␣-subunit with no detectable specific photoincorporation in ␦-subunit (19) . [ 3 H]dTC is unusual because its efficiency of photoincorporation into the non-␣-subunits (␥ and ␦) was equal to or greater than into the ␣-subunits. 3 H]dTC-labeled ␥-subunit (190 g, 230,000 cpm, from the labeling described in Fig. 4) was incubated with 0.3 units of endoproteinase Lys-C (3 weeks at 25°C) and subsequently fractionated by SDS-PAGE (Tricine 10% T, 3% C). A, 3 H distribution (q) was determined by scintillation counting of a strip of the gel (25 g, 30,000 cpm of the ␥-subunit digest) cut into 2-mm segments. A single prominent peak of 3 H was noted at 27 kDa (P) with a shoulder of 3 H at 24 kDa (S). The remainder of the gel was treated with Amplify TM , dried, and submitted for fluorography (48 h). The fluorogram was used as a template to excise the bands corresponding to the peaks of activity in A (horizontal bracket). B, 3 H (q) release profile when material eluted from band P was sequenced (44,000 cpm loaded, 11,000 cpm left on the filter after 36 cycles of Edman degradation). Two ␥-subunit fragments were detected: ␥Glu-47 (Ⅺ, I ϭ 31 pmol, R ϭ 93%) and ␥Thr-24 (ƒ, I ϭ 23 pmol, R ϭ 90%): The dotted lines represent a best fit of the mass values calculated as described under "Experimental Procedures." Release of 3 H was detected in cycles 9, 21, and 32 (1700, 180, and 100 cpm, respectively), with release in cycle 9 and 32 consistent with [ 3 H]dTC incorporation into ␥Trp-55 from the ␥Glu-47 and ␥Thr-24 fragments, respectively. The release in cycle 21 could reflect labeling at ␥Trp-55 if partial cleavage occurred after the other lysine in this region, ␥Lys-34. Calculated specific activities for ␥Trp-55 were 70 cpm/pmol (cycle 9) and 84 cpm/pmol (cycle 32). Sequence analysis of band S produced similar results (␥Glu-47, I ϭ 10 pmol, R ϭ 92%, release in cycle 9, 470 cpm, labeling at ␥Trp-55, 81 cpm/pmol.) Table III . Masses of detected PTH-derivatives and 3 H release detected for the 8 kDa band (3,000 cpm loaded, 540 cpm left after 23 cycles). The fragment beginning at ␥Val-102 was identified (I ϭ 17 pmol, R ϭ 87%). ␥Leu-373 was also present (I ϭ 9 pmol, R ϭ 83%), whereas ␥Ala-49 was not detected (Ͻ1 pmol). Prominent release of 3 H was detected in the 7th cycle in Tables II and III  ( when ␥Ala-49 was present) but not in Table IV 
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essential for proper subunit assembly, since functional receptors are obtained after replacement of tryptophan by tyrosine, threonine, or leucine (42, 43) . For Torpedo nAChR expressed in Xenopus oocytes, replacement of ␥Trp-55 by leucine decreased ACh potency by 10-fold and also reduced by 10-fold the potency of dTC as an inhibitor of ACh-induced currents (43) . However, direct analysis of the equilibrium binding of dTC to this mutant receptor establishes that dTC binding is the same as for wildtype and that the weakening of dTC potency occurs because there is a major perturbation of the mechanism of channel activation by agonist (44) . 2 Since tryptophan is conserved at this position in ␥-, ␦-, and ⑀-subunits, it cannot contribute directly to the difference of dTC binding affinity at the two agonist sites. For embryonic mouse nAChR that difference can be accounted for by differences between ␥-and ␦-subunits at positions equivalent to ␥116, ␥117, and ␥161 (15). Interestingly, for mouse nAChR ␥Glu-57 and ␦Asp-59 do contribute to the difference in agonist binding at the ␣-␥ and ␣-␦ sites (45) . For the ␣7 homooligomeric neuronal nAChR, replacement of the equivalent tryptophan (␣7Trp-54) by Phe, Ala, and His affects both agonist and antagonist binding (46) . For neuronal ␤2 and ␤4 subunits, the tryptophan is conserved (␤2Trp-57), but the amino acid at position 59 (␤2Thr-59/␤4Lys-59) plays an important role in determining the potency of competitive antagonists (47) . The results of these mutational analyses all indicate that the region of primary structure near ␥Trp-55 plays an important role in the interactions of agonists and antagonists with nAChRs, whereas our photoaffinity labeling studies with [ 3 H]dTC establish that ␥Trp-55/␦Trp-57 are actually located within the agonist binding sites.
This region of subunit primary structure is also likely to be within the agonist binding site for other members of this family of ligand-gated ion channels. For ␣1␤2␥2 GABA A receptors, replacement of the equivalent position, ␣1Phe-64, by leucine results in 200-fold decrease in agonist potency, whereas substitution of the equivalent positions in other subunits were without effect on agonist potency (48) . In contrast, substitution at the equivalent position in ␥2-subunit (␥2Phe-77) selectively alters binding of ligands at the benzodiazepine site (49) .
In conclusion, the major sites of [ 3 H]dTC photoincorporation occur at ␣Tyr-190, ␥Trp-55, and ␦Trp-57. [ 3 H]dTC's photolabeling of ␥Trp-55 and ␦Trp-57 identifies a novel region of the agonist binding sites across the interface from the ␣-subunits and provides further evidence that each agonist binding site is not located primarily within an ␣-subunit but includes significant contributions from the corresponding ␥-or ␦-subunit. Although photoincorporation with [ 3 H]dTC has localized ␣Tyr-190 and ␥Trp-55/␦Trp-57 to the agonist site region, a better understanding about the photochemistry of dTC will be necessary to determine the structural relationship between this ␣-subunit tyrosine and the ␥-/␦-subunit tryptophan.
